[Congressional Record Volume 159, Number 164 (Monday, November 18, 2013)]
[Senate]
[Pages S8136-S8140]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
PEPFAR STEWARDSHIP AND OVERSIGHT ACT OF 2013
Mrs. BOXER. Mr. President, I ask unanimous consent that the Senate
proceed to the immediate consideration of Calendar No. 202, S. 1545.
The PRESIDING OFFICER. The clerk will report the bill by title.
The legislative clerk read as follows:
A bill (S. 1545) to extend authorities related to global
HIV/AIDS and to promote oversight of United States programs.
There being no objection, the Senate proceeded to consider the bill
which
[[Page S8137]]
had been reported from the Committee on Foreign Relations, with
amendments, as follows:
(The parts of the bill intended to be stricken are shown in
boldface brackets and the parts of the bill intended to be
inserted are shown in italics.)
S. 1545
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``PEPFAR Stewardship and
Oversight Act of 2013''.
SEC. 2. INSPECTOR GENERAL OVERSIGHT.
Section 101(f)(1) of the United States Leadership Against
HIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22 U.S.C.
7611(f)(1)) is amended--
(1) in subparagraph (A), by striking ``5 coordinated annual
plans for oversight activity in each of the fiscal years 2009
through 2013'' and inserting ``coordinated annual plans for
oversight activity in each of the fiscal years 2009 through
2018''; and
(2) in subparagraph (C)--
(A) in clause (ii)--
(i) in the heading, by striking ``Subsequent'' and
inserting ``2010 through 2013''; and
(ii) by striking ``the last four plans'' and inserting
``the plans for fiscal years 2010 through 2013''; and
(B) by adding at the end the following new clause:
``(iii) 2014 plan.--The plan developed under subparagraph
(A) for fiscal year 2014 shall be completed not later than 60
days after the date of the enactment of the PEPFAR
Stewardship and Oversight Act of 2013.
``(iv) Subsequent plans.--Each of the last four plans
developed under subparagraph (A) shall be completed not later
than 30 days before each of the fiscal years 2015 through
2018, respectively.''.
SEC. 3. ANNUAL TREATMENT STUDY.
(a) Annual Study; Message.--Section 101(g) of the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Act of 2003 (22 U.S.C. 7611(g)) is amended--
(1) in paragraph (1), by striking ``through September 30,
2013'' and inserting ``through September 30, 2019'';
(2) by redesignating paragraph (2) as paragraph (3);
(3) by inserting after paragraph (1) the following new
paragraph:
``(2) 2013 through 2018 studies.--The studies required to
be submitted by September 30, 2014, and annually thereafter
through September 30, 2018, shall include, in addition to the
elements set forth under paragraph (1), the following
elements:
``(A) A plan for conducting cost studies of United States
assistance under section 104A of the Foreign Assistance Act
of 1961 (22 U.S.C. 2151b-2) in partner countries, taking into
account the goal for more systematic collection of data, as
well as the demands of such analysis on available human and
fiscal resources.
``(B) A comprehensive and harmonized expenditure analysis
by partner country, including--
``(i) an analysis of Global Fund and national partner
spending and comparable data across United States, Global
Fund, and national partner spending; or
``(ii) where providing such comparable data is not
currently practicable, an explanation of why it is not
currently practicable, and when it will be practicable.'';
and
(4) by adding at the end the following new paragraph:
``(4) Partner country defined.--In this subsection, the
term `partner country' means a country with a minimum United
States Government investment of HIV/AIDS assistance of at
least $5,000,000 [annually] in the prior fiscal year.''.
SEC. 4. PARTICIPATION IN THE GLOBAL FUND TO FIGHT AIDS,
TUBERCULOSIS, AND MALARIA.
(a) Limitation.--Section 202(d)(4) of the United States
Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of
2003 (22 U.S.C. 7622(d)(4)) is amended--
(1) in subparagraph (A)--
(A) in clause (i), by striking ``2013'' and inserting
``2018'';
(B) in clause (ii)--
(i) by striking ``2013'' and inserting ``2018''; and
(ii) by striking the last two sentences; and
(C) in clause (vi), by striking ``2013'' and inserting
``2018''; and
(2) in subparagraph (B)--
(A) by striking ``under this subsection'' each place it
appears;
(B) in clause (ii), by striking ``pursuant to the
authorization of appropriations under section 401'' and
inserting ``to carry out section 104A of the Foreign
Assistance Act of 1961''; and
(C) in clause (iv), by striking ``2013'' and inserting
``2018''.
(b) Withholding Funds.--Section 202(d)(5) of the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Act of 2003 (22 U.S.C. 7622(d)) is amended by--
(1) in paragraph (5)--
(A) by striking ``2013'' and inserting ``2018'';
(B) in subparagraph (C)--
(i) by inserting ``in an open, machine readable format''
after ``site'';
(ii) by amending clause (v) to read as follows:
``(v) a regular collection, analysis, and reporting of
performance data and funding of grants of the Global Fund,
which covers all principal recipients and all subrecipients
on the fiscal cycle of each grant, and includes the
distribution of resources, by grant and principal recipient
and subrecipient, for prevention, care, treatment, drugs, and
commodities purchase, and other purposes as practicable;'';
(C) in subparagraph (D)(ii), by inserting ``, in an open,
machine readable format,'' after ``audits'';
(D) in subparagraph (E), by inserting ``, in an open,
machine readable format,'' after ``publicly'';
(E) in subparagraph (F)--
(i) in clause (i), by striking ``; and'' and inserting a
semicolon; and
(ii) by striking clause (ii) and inserting the following
new clauses:
``(ii) all principal recipients and subrecipients and the
amount of funds disbursed to each principal recipient and
subrecipient on the fiscal cycle of the grant;
``(iii) expenditure data--
``(I) tracked by principal recipients and subrecipients [by
prevention, care, and treatment as practicable] by program
area, where practicable, prevention, care, and treatment and
reported in a format that allows comparison with other
funding streams in each country; or
``(II) if such expenditure data is not available, outlay or
disbursement data, and an explanation of progress made toward
providing such expenditure data; and
``(iv) high-quality grant performance evaluations measuring
inputs, outputs, and outcomes, as appropriate, with the goal
of achieving outcome reporting;''; and
(F) by amending subparagraph (G) to read as follows:
``(G) has published an annual report on a publicly
available Web site in an open, machine readable format, that
includes--
``(i) a list of all countries imposing import duties and
internal taxes on any goods or services financed by the
Global Fund;
``(ii) a description of the types of goods or services on
which the import duties and internal taxes are levied;
``(iii) the total cost of the import duties and internal
taxes;
``(iv) recovered import duties or internal taxes; and
``(v) the status of country status-agreements;''.
SEC. 5. ANNUAL REPORT.
Section 104A(f) of the Foreign Assistance Act of 1961 (22
U.S.C. 2151b-2(f)) is amended to read as follows:
``(f) Annual Report.--
``(1) In general.--Not later than February 15, 2014, and
annually thereafter, the President shall submit to the
Committee on Foreign Relations of the Senate and the
Committee on Foreign Affairs of the House of Representatives
a report in an open, machine readable format, on the
implementation of this section for the prior fiscal year.
``(2) Report due in 2014.--The report due not later than
February 15, 2014, shall include the elements required by law
prior to the enactment of the PEPFAR Stewardship and
Oversight Act of 2013.
``[2](3) Report elements.--Each report submitted after
February 15, 2014, shall include the following:
``(A) A description based on internationally available
data, and where practicable high-quality country-based data,
of the total global burden and need for HIV/AIDS prevention,
treatment, and care, including--
``(i) estimates by partner country of the global burden and
need; and
``(ii) HIV incidence, prevalence, and AIDS deaths for the
reporting period.
``(B) Reporting on annual targets across prevention,
treatment, and care interventions in partner countries,
including--
``(i) a description of how those targets are designed to--
``(I) ensure that the annual increase in new patients on
antiretroviral treatment exceeds the number of annual new HIV
infections;
``(II) reduce the number of new HIV infections below the
number of deaths among persons infected with HIV; and
``(III) achieve an AIDS-free generation;
``(ii) national targets across prevention, treatment, and
care that are--
``(I) established by partner countries; or
``(II) where such national partner country-developed
targets are unavailable, a description of progress towards
developing national partner country targets; and
``(iii) bilateral programmatic targets across prevention,
treatment, and care, including--
``(I) the number of adults and children to be directly
supported on HIV treatment under United States-funded
programs;
``(II) the number of adults and children to be otherwise
supported on HIV treatment under United States-funded
programs; and
``(III) other programmatic targets for activities directly
and otherwise supported by United States-funded programs.
[[Page S8138]]
``(C) A description, by partner country, of HIV/AIDS
funding from all sources, including funding levels from
partner countries, other donors, and the private sector, as
practicable.
``(D) A description of how United States-funded programs,
in conjunction with the Global Fund, other donors, and
partner countries, together set targets, measure progress,
and achieve positive outcomes in partner countries.
``(E) An annual assessment of outcome indicator
development, dissemination, and performance for programs
supported under this section, including ongoing corrective
actions to improve reporting.
``(F) A description and explanation of changes in related
guidance or policies related to implementation of programs
supported under this section.
``(G) An assessment and quantification of progress over the
reporting period toward achieving the targets set forth in
subparagraph (B), including--
``(i) the number, by partner country, of persons on HIV
treatment, including specifically--
``(I) the number of adults and children on HIV treatment
directly supported by United States-funded programs; and
``(II) the number of adults and children on HIV treatment
otherwise supported by United States-funded programs;
``(ii) HIV treatment coverage rates by partner country;
``(iii) the net increase in persons on HIV treatment by
partner country;
``(iv) new infections of HIV by partner country;
``(v) the number of HIV infections averted;
``(vi) antiretroviral treatment program retention rates by
partner country, including--
``(I) performance against annual targets for program
retention; and
``(II) the retention rate of persons on HIV treatment
directly supported by United States-funded programs; and
``(vii) a description of supportive care [including
management of co-morbidities]
``(H) A description of [national] partner country and
United States-funded HIV/AIDS prevention programs and
policies, including--
``(i) an assessment by country of progress towards targets
set forth in subparagraph (B), with a detailed description of
the metrics used to assess--
``(I) programs to prevent mother to child transmission of
HIV/AIDS, including coverage rates;
``(II) programs to provide or promote voluntary medical
male circumcision, including coverage rates;
``(III) programs for behavior-change; and
``(IV) other programmatic activities to prevent the
transmission of HIV;
``(ii) antiretroviral treatment as prevention; and
``(iii) a description of any new preventative interventions
or methodologies.
``(I) A description of the goals, scope, and measurement of
program efforts aimed at women and girls.
``(J) A description of the goals, scope, and measurement of
program efforts aimed at orphans, vulnerable children, and
youth.
``(K) A description of the indicators and milestones used
to assess effective, strategic, and appropriately timed
country ownership, including--
``(i) an explanation of the metrics used to determine
whether the pace of any transition to such ownership is
appropriate for that country, given that country's level of
readiness for such transition;
``(ii) an analysis of governmental and local
nongovernmental capacity to sustain positive outcomes;
``(iii) a description of measures taken to improve partner
country capacity to sustain positive outcomes where needed;
and
``(iv) for countries undergoing a transition to greater
country ownership, a description of strategies to assess and
mitigate programmatic and financial risk and to ensure
continued quality of care for essential services.
``(L) A description, globally and by partner country, of
specific efforts to achieve and incentivize greater
programmatic and cost effectiveness, including--
``(i) progress toward establishing common economic metrics
across prevention, care and treatment with partner countries
and the Global Fund;
``(ii) average costs, by country and by core intervention;
``(iii) expenditure reporting in all program areas,
supplemented with targeted analyses of the cost-effectiveness
of specific interventions; and
``(iv) import duties and internal taxes imposed on program
commodities and services, by country.
``(M) A description of partnership framework agreements
with countries, and regions where applicable, including--
``(i) the objectives and structure of partnership framework
agreements with countries, including--
``(I) how these agreements are aligned with national HIV/
AIDS plans and public health strategies and commitments of
such countries; and
``(II) how these agreements incorporate a role for civil
society; and
``(ii) a description of what has been learned in advancing
partnership framework agreements with countries, and regions
as applicable, in terms of improved coordination and
collaboration, definition of clear roles and responsibilities
of participants and signers, and implications for how to
further strengthen these agreements with mutually accountable
measures of progress.
``(N) A description of efforts and activities to engage new
partners, including faith-based, [community based] locally-
based, and United States minority-serving institutions.
``(O) A definition and description of the differentiation
between directly and otherwise supported activities,
including specific efforts to clarify programmatic
attribution and contribution, as well as timelines for
dissemination and implementation.
``(P) A description, globally and by country, of specific
efforts to address co-infections and co-morbidities of HIV/
AIDS, including--
``(i) the number and percent of people in HIV care or
treatment who started tuberculosis treatment; and
``(ii) the number and percentage of eligible HIV positive
patients starting isoniazid preventative therapy.
``(Q) A description of efforts by partner countries to
train, employ, and retain health care workers, including
efforts to address workforce shortages.
``[(3)](4) Partner country defined.--In this subsection,
the term `partner country' means a country with a minimum
United States Government investment of HIV/AIDS assistance of
at least $5,000,000 [annually] in the prior fiscal year.''.
SEC. 6. ALLOCATION OF FUNDING.
(a) Orphans and Vulnerable Children.--Section 403(b) of the
United States Leadership Against HIV/AIDS, Tuberculosis, and
Malaria Act of 2003 (22 U.S.C. 7673(b)) is amended--
(1) by striking ``2013'' and inserting ``2018''; and
(2) by striking ``amounts appropriated pursuant to the
authorization of appropriations under section 401'' and
inserting ``amounts appropriated or otherwise made available
to carry out the provisions of section 104A of the Foreign
Assistance Act of 1961 (22 U.S.C. 2151b-2)''.
(b) Funding Allocation.--Section 403(c) of the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Act of 2003 (22 U.S.C. 7673(c)) is amended--
(1) by striking ``2013'' and inserting ``2018''; and
(2) by striking ``amounts appropriated for bilateral global
HIV/AIDS assistance pursuant to section 401'' and inserting
``amounts appropriated or otherwise made available to carry
out the provisions of section 104A of the Foreign Assistance
Act of 1961 (22 U.S.C. 2151b-2)''.
Mrs. BOXER. Mr. President, I ask unanimous consent that the
committee-reported amendments be agreed to as original text, the
Menendez-Corker amendment, which is at the desk, be agreed to, the
bill, as amended, be read a third time and passed, and the motion to
reconsider be considered made and laid upon the table, with no
intervening action or debate.
The PRESIDING OFFICER. Without objection, it is so ordered.
The committee-reported amendments were agreed to.
The amendment (No. 2147) was agreed to, as follows:
(Purpose: To require reporting on program evaluations)
On page 18, strike line 11 and insert the following:
``(R) A description of program evaluations completed during
the reporting period, including whether all completed
evaluations have been published on a publically available
Internet website and whether any completed evaluations did
not adhere to the common evaluation standards of practice
published under paragraph (4).
``(4) Common evaluation standards.--Not later than February
1, 2014, the Global AIDS Coordinator shall publish on a
publically available Internet website the common evaluation
standards of practice referred to in paragraph (3)(R).
``(5) Partner country defined.--In this
On page 16, line 3, strike ``counties'' and insert
``countries''.
On page 18, line 1, strike the second set of quotation
marks.
On page 18, line 4, strike the second set of quotation
marks.
The bill (S. 1545), as amended, was ordered to be engrossed for a
third reading, was read the third time, and passed, as follows:
S. 1545
Be it enacted by the Senate and House of Representatives of
the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``PEPFAR Stewardship and
Oversight Act of 2013''.
SEC. 2. INSPECTOR GENERAL OVERSIGHT.
Section 101(f)(1) of the United States Leadership Against
HIV/AIDS, Tuberculosis, and Malaria Act of 2003 (22 U.S.C.
7611(f)(1)) is amended--
(1) in subparagraph (A), by striking ``5 coordinated annual
plans for oversight activity in each of the fiscal years 2009
through 2013'' and inserting ``coordinated annual plans for
oversight activity in each of the fiscal years 2009 through
2018''; and
(2) in subparagraph (C)--
(A) in clause (ii)--
(i) in the heading, by striking ``Subsequent'' and
inserting ``2010 through 2013''; and
[[Page S8139]]
(ii) by striking ``the last four plans'' and inserting
``the plans for fiscal years 2010 through 2013''; and
(B) by adding at the end the following new clause:
``(iii) 2014 plan.--The plan developed under subparagraph
(A) for fiscal year 2014 shall be completed not later than 60
days after the date of the enactment of the PEPFAR
Stewardship and Oversight Act of 2013.
``(iv) Subsequent plans.--Each of the last four plans
developed under subparagraph (A) shall be completed not later
than 30 days before each of the fiscal years 2015 through
2018, respectively.''.
SEC. 3. ANNUAL TREATMENT STUDY.
(a) Annual Study; Message.--Section 101(g) of the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Act of 2003 (22 U.S.C. 7611(g)) is amended--
(1) in paragraph (1), by striking ``through September 30,
2013'' and inserting ``through September 30, 2019'';
(2) by redesignating paragraph (2) as paragraph (3);
(3) by inserting after paragraph (1) the following new
paragraph:
``(2) 2013 through 2018 studies.--The studies required to
be submitted by September 30, 2014, and annually thereafter
through September 30, 2018, shall include, in addition to the
elements set forth under paragraph (1), the following
elements:
``(A) A plan for conducting cost studies of United States
assistance under section 104A of the Foreign Assistance Act
of 1961 (22 U.S.C. 2151b-2) in partner countries, taking into
account the goal for more systematic collection of data, as
well as the demands of such analysis on available human and
fiscal resources.
``(B) A comprehensive and harmonized expenditure analysis
by partner country, including--
``(i) an analysis of Global Fund and national partner
spending and comparable data across United States, Global
Fund, and national partner spending; or
``(ii) where providing such comparable data is not
currently practicable, an explanation of why it is not
currently practicable, and when it will be practicable.'';
and
(4) by adding at the end the following new paragraph:
``(4) Partner country defined.--In this subsection, the
term `partner country' means a country with a minimum United
States Government investment of HIV/AIDS assistance of at
least $5,000,000 in the prior fiscal year.''.
SEC. 4. PARTICIPATION IN THE GLOBAL FUND TO FIGHT AIDS,
TUBERCULOSIS, AND MALARIA.
(a) Limitation.--Section 202(d)(4) of the United States
Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of
2003 (22 U.S.C. 7622(d)(4)) is amended--
(1) in subparagraph (A)--
(A) in clause (i), by striking ``2013'' and inserting
``2018'';
(B) in clause (ii)--
(i) by striking ``2013'' and inserting ``2018''; and
(ii) by striking the last two sentences; and
(C) in clause (vi), by striking ``2013'' and inserting
``2018''; and
(2) in subparagraph (B)--
(A) by striking ``under this subsection'' each place it
appears;
(B) in clause (ii), by striking ``pursuant to the
authorization of appropriations under section 401'' and
inserting ``to carry out section 104A of the Foreign
Assistance Act of 1961''; and
(C) in clause (iv), by striking ``2013'' and inserting
``2018''.
(b) Withholding Funds.--Section 202(d)(5) of the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Act of 2003 (22 U.S.C. 7622(d)) is amended by--
(1) in paragraph (5)--
(A) by striking ``2013'' and inserting ``2018'';
(B) in subparagraph (C)--
(i) by inserting ``in an open, machine readable format''
after ``site'';
(ii) by amending clause (v) to read as follows:
``(v) a regular collection, analysis, and reporting of
performance data and funding of grants of the Global Fund,
which covers all principal recipients and all subrecipients
on the fiscal cycle of each grant, and includes the
distribution of resources, by grant and principal recipient
and subrecipient, for prevention, care, treatment, drugs, and
commodities purchase, and other purposes as practicable;'';
(C) in subparagraph (D)(ii), by inserting ``, in an open,
machine readable format,'' after ``audits'';
(D) in subparagraph (E), by inserting ``, in an open,
machine readable format,'' after ``publicly'';
(E) in subparagraph (F)--
(i) in clause (i), by striking ``; and'' and inserting a
semicolon; and
(ii) by striking clause (ii) and inserting the following
new clauses:
``(ii) all principal recipients and subrecipients and the
amount of funds disbursed to each principal recipient and
subrecipient on the fiscal cycle of the grant;
``(iii) expenditure data--
``(I) tracked by principal recipients and subrecipients by
program area, where practicable, prevention, care, and
treatment and reported in a format that allows comparison
with other funding streams in each country; or
``(II) if such expenditure data is not available, outlay or
disbursement data, and an explanation of progress made toward
providing such expenditure data; and
``(iv) high-quality grant performance evaluations measuring
inputs, outputs, and outcomes, as appropriate, with the goal
of achieving outcome reporting;''; and
(F) by amending subparagraph (G) to read as follows:
``(G) has published an annual report on a publicly
available Web site in an open, machine readable format, that
includes--
``(i) a list of all countries imposing import duties and
internal taxes on any goods or services financed by the
Global Fund;
``(ii) a description of the types of goods or services on
which the import duties and internal taxes are levied;
``(iii) the total cost of the import duties and internal
taxes;
``(iv) recovered import duties or internal taxes; and
``(v) the status of country status-agreements;''.
SEC. 5. ANNUAL REPORT.
Section 104A(f) of the Foreign Assistance Act of 1961 (22
U.S.C. 2151b-2(f)) is amended to read as follows:
``(f) Annual Report.--
``(1) In general.--Not later than February 15, 2014, and
annually thereafter, the President shall submit to the
Committee on Foreign Relations of the Senate and the
Committee on Foreign Affairs of the House of Representatives
a report in an open, machine readable format, on the
implementation of this section for the prior fiscal year.
``(2) Report due in 2014.--The report due not later than
February 15, 2014, shall include the elements required by law
prior to the enactment of the PEPFAR Stewardship and
Oversight Act of 2013.
``(3) Report elements.--Each report submitted after
February 15, 2014, shall include the following:
``(A) A description based on internationally available
data, and where practicable high-quality country-based data,
of the total global burden and need for HIV/AIDS prevention,
treatment, and care, including--
``(i) estimates by partner country of the global burden and
need; and
``(ii) HIV incidence, prevalence, and AIDS deaths for the
reporting period.
``(B) Reporting on annual targets across prevention,
treatment, and care interventions in partner countries,
including--
``(i) a description of how those targets are designed to--
``(I) ensure that the annual increase in new patients on
antiretroviral treatment exceeds the number of annual new HIV
infections;
``(II) reduce the number of new HIV infections below the
number of deaths among persons infected with HIV; and
``(III) achieve an AIDS-free generation;
``(ii) national targets across prevention, treatment, and
care that are--
``(I) established by partner countries; or
``(II) where such national partner country-developed
targets are unavailable, a description of progress towards
developing national partner country targets; and
``(iii) bilateral programmatic targets across prevention,
treatment, and care, including--
``(I) the number of adults and children to be directly
supported on HIV treatment under United States-funded
programs;
``(II) the number of adults and children to be otherwise
supported on HIV treatment under United States-funded
programs; and
``(III) other programmatic targets for activities directly
and otherwise supported by United States-funded programs.
``(C) A description, by partner country, of HIV/AIDS
funding from all sources, including funding levels from
partner countries, other donors, and the private sector, as
practicable.
``(D) A description of how United States-funded programs,
in conjunction with the Global Fund, other donors, and
partner countries, together set targets, measure progress,
and achieve positive outcomes in partner countries.
``(E) An annual assessment of outcome indicator
development, dissemination, and performance for programs
supported under this section, including ongoing corrective
actions to improve reporting.
``(F) A description and explanation of changes in related
guidance or policies related to implementation of programs
supported under this section.
``(G) An assessment and quantification of progress over the
reporting period toward achieving the targets set forth in
subparagraph (B), including--
``(i) the number, by partner country, of persons on HIV
treatment, including specifically--
``(I) the number of adults and children on HIV treatment
directly supported by United States-funded programs; and
``(II) the number of adults and children on HIV treatment
otherwise supported by United States-funded programs;
``(ii) HIV treatment coverage rates by partner country;
``(iii) the net increase in persons on HIV treatment by
partner country;
``(iv) new infections of HIV by partner country;
``(v) the number of HIV infections averted;
``(vi) antiretroviral treatment program retention rates by
partner country, including--
``(I) performance against annual targets for program
retention; and
[[Page S8140]]
``(II) the retention rate of persons on HIV treatment
directly supported by United States-funded programs; and
``(vii) a description of supportive care.
``(H) A description of partner country and United States-
funded HIV/AIDS prevention programs and policies, including--
``(i) an assessment by country of progress towards targets
set forth in subparagraph (B), with a detailed description of
the metrics used to assess--
``(I) programs to prevent mother to child transmission of
HIV/AIDS, including coverage rates;
``(II) programs to provide or promote voluntary medical
male circumcision, including coverage rates;
``(III) programs for behavior-change; and
``(IV) other programmatic activities to prevent the
transmission of HIV;
``(ii) antiretroviral treatment as prevention; and
``(iii) a description of any new preventative interventions
or methodologies.
``(I) A description of the goals, scope, and measurement of
program efforts aimed at women and girls.
``(J) A description of the goals, scope, and measurement of
program efforts aimed at orphans, vulnerable children, and
youth.
``(K) A description of the indicators and milestones used
to assess effective, strategic, and appropriately timed
country ownership, including--
``(i) an explanation of the metrics used to determine
whether the pace of any transition to such ownership is
appropriate for that country, given that country's level of
readiness for such transition;
``(ii) an analysis of governmental and local
nongovernmental capacity to sustain positive outcomes;
``(iii) a description of measures taken to improve partner
country capacity to sustain positive outcomes where needed;
and
``(iv) for countries undergoing a transition to greater
country ownership, a description of strategies to assess and
mitigate programmatic and financial risk and to ensure
continued quality of care for essential services.
``(L) A description, globally and by partner country, of
specific efforts to achieve and incentivize greater
programmatic and cost effectiveness, including--
``(i) progress toward establishing common economic metrics
across prevention, care and treatment with partner countries
and the Global Fund;
``(ii) average costs, by country and by core intervention;
``(iii) expenditure reporting in all program areas,
supplemented with targeted analyses of the cost-effectiveness
of specific interventions; and
``(iv) import duties and internal taxes imposed on program
commodities and services, by country.
``(M) A description of partnership framework agreements
with countries, and regions where applicable, including--
``(i) the objectives and structure of partnership framework
agreements with countries, including--
``(I) how these agreements are aligned with national HIV/
AIDS plans and public health strategies and commitments of
such countries; and
``(II) how these agreements incorporate a role for civil
society; and
``(ii) a description of what has been learned in advancing
partnership framework agreements with countries, and regions
as applicable, in terms of improved coordination and
collaboration, definition of clear roles and responsibilities
of participants and signers, and implications for how to
further strengthen these agreements with mutually accountable
measures of progress.
``(N) A description of efforts and activities to engage new
partners, including faith-based, locally-based, and United
States minority-serving institutions.
``(O) A definition and description of the differentiation
between directly and otherwise supported activities,
including specific efforts to clarify programmatic
attribution and contribution, as well as timelines for
dissemination and implementation.
``(P) A description, globally and by country, of specific
efforts to address co-infections and co-morbidities of HIV/
AIDS, including--
``(i) the number and percent of people in HIV care or
treatment who started tuberculosis treatment; and
``(ii) the number and percentage of eligible HIV positive
patients starting isoniazid preventative therapy.
``(Q) A description of efforts by partner countries to
train, employ, and retain health care workers, including
efforts to address workforce shortages.
``(R) A description of program evaluations completed during
the reporting period, including whether all completed
evaluations have been published on a publically available
Internet website and whether any completed evaluations did
not adhere to the common evaluation standards of practice
published under paragraph (4).
``(4) Common evaluation standards.--Not later than February
1, 2014, the Global AIDS Coordinator shall publish on a
publically available Internet website the common evaluation
standards of practice referred to in paragraph (3)(R).
``(5) Partner country defined.--In this subsection, the
term `partner country' means a country with a minimum United
States Government investment of HIV/AIDS assistance of at
least $5,000,000 in the prior fiscal year.''.
SEC. 6. ALLOCATION OF FUNDING.
(a) Orphans and Vulnerable Children.--Section 403(b) of the
United States Leadership Against HIV/AIDS, Tuberculosis, and
Malaria Act of 2003 (22 U.S.C. 7673(b)) is amended--
(1) by striking ``2013'' and inserting ``2018''; and
(2) by striking ``amounts appropriated pursuant to the
authorization of appropriations under section 401'' and
inserting ``amounts appropriated or otherwise made available
to carry out the provisions of section 104A of the Foreign
Assistance Act of 1961 (22 U.S.C. 2151b-2)''.
(b) Funding Allocation.--Section 403(c) of the United
States Leadership Against HIV/AIDS, Tuberculosis, and Malaria
Act of 2003 (22 U.S.C. 7673(c)) is amended--
(1) by striking ``2013'' and inserting ``2018''; and
(2) by striking ``amounts appropriated for bilateral global
HIV/AIDS assistance pursuant to section 401'' and inserting
``amounts appropriated or otherwise made available to carry
out the provisions of section 104A of the Foreign Assistance
Act of 1961 (22 U.S.C. 2151b-2)''.
____________________